Eczacıbaşı Group’s new health ecosystem, Evital, has entered into a collaboration with Huma Therapeutics (“Huma”), a global healthcare AI company. Mr. Emin Fadıllıoğlu, the Chairman of Eczacıbaşı Evital, said, "We are delighted to bring the competencies of Huma, which has a strong global experience, to Türkiye."
‍
Turkey’s leading health ecosystem Evital is today announcing a strategic partnership with global digital health business Huma Therapeutics as it expands its suite of health solutions for its users.
‍
Evital allows users to manage their health information from a single point. With over 1,000 doctors and a total of 3,000 health professionals in its ecosystem, Evital serves more than 30,000 individuals seeking health solutions and the organizations that prioritize supporting the well-being of their employees. The app enables individuals to carry out online or face-to-face consultations with doctors, dieticians, and psychologists as well as tracking laboratory services.
‍
Through its partnership with Huma, Evital intends to enhance its proactive care offerings by incorporating Huma’s advanced tools for real-world data collection, self-management and remote monitoring. Huma will provide Evital with access to the Huma Cloud Platform, which includes a range of cutting-edge solutions, including remote patient monitoring programmes, companion apps, multi-device connectivity, risk assessment tools and algorithms powered by artificial intelligence, including generative AI (GenAI) capabilities. Evital will now be able to deepen the care provision for individuals outside of the traditional hospital setting, while reducing the burden on healthcare providers and systems, opening the potential for more proactive and preventative care. Together, Huma and Evital hope to leverage AI capabilities to expand access to high quality care and support health and wellbeing at scale.
‍
The Chairman of Eczacıbaşı Evital, Emin Fadıllıoğlu emphasised that real-world data, if used for the good of society, can add tremendous value in management of illness, understanding of treatment efficacy and delivery of personalized interventions. He added, “We are observing how the rise of AI, which we closely monitor, is manifesting itself in the field of health care. As a part of the work we carry out at Eczacıbaşı Evital, we have embarked on a partnership with Huma, one of the leaders of global digital health technology companies that uses AI tools to improve proactive care.
‍
Huma provides personalised insights generated from a patient’s medical history and health data, to optimise care and outcomes. Huma’s regulated Software as a Medical Device is the only disease- and device-agnostic platform to hold EU MDR Class IIb, US FDA (510k) Class II, India CDSCO Class-C, Saudi Arabia SFDA Class-C, and Australia TGA Class-IIb clearance. We are delighted to be bringing this global innovation, competence, and experience to Türkiye.”
‍
Mr. Fadıllıoğlu added, “I believe that we have signed an agreement that will add value to our users and business partners.”
‍
Dan Vahdat, CEO & Founder of Huma, said: “We are thrilled to announce our strategic collaboration with Eczacıbaşı Evital to establish a comprehensive 360-degree ecosystem for digital healthcare, empowering patients throughout their health journey. Over the past decade, we have dedicated ourselves to developing Huma Cloud Platform, a highly configurable, flexible, disease-agnostic, and regulated technology platform. I take pride in the fact that Huma is partnering with Eczacıbaşı Evital to leverage our platform, bringing digital health solutions to Türkiye and supporting individuals in Türkiye to lead longer, fuller lives.”

‍

About Evital

Evital is a member of the Eczacıbaşı Group, which prioritizes contributions to public health with the vision of being a pioneer of modern, high quality and healthy living. With its new health ecosystem identity, Evital serves those seeking health solutions, health professionals and health service providers. Established to facilitate the transition to healthy living, Evital offers digital solutions that will bring ease to individuals in line with their needs. Evital is one of the first software companies to have received "Remote Health Information System Accreditation". Offering the services of health professionals for those seeking advice about their health through its web and mobile applications, the company offers conscious health consumers the health services they want where they want.

‍
About Huma

Huma is a global healthcare AI company on a mission to accelerate the adoption of digital solutions in care and research. Huma’s technology has powered over 3,000 hospitals and clinics, with 500+ unique deployments across 70+ countries. The software has been used to engage and screen over 35 million individuals, with 1.8 million active users across its various products. The company is renowned for its role in major national healthcare projects worldwide, from the US and the UK to Germany, Greece, and Saudi Arabia, as well as working with most large pharma companies and CROs.
‍
The Huma Cloud Platform offers a technology infrastructure built on strong regulatory foundations to launch digital solutions for healthcare and research. Huma has achieved FDA 510(k) Class II, EU/MDR Class IIb, and Saudi FDA Class C regulatory clearance for its disease-agnostic flagship product, enabling rapid, code-free configuration with the ability to host AI/ML models.